Target intelligence / Profile preview

Zinc transporter SLC39A7 (SLC39A7 (or ZIP7))

Target
SLC39A7 (or ZIP7)
Molecular classification
Transporter, Solute carrier family protein, Metal ion transporter
01

Overview

Zinc transporter SLC39A7 (ZIP7) is a transmembrane protein encoded by the SLC39A7 gene in humans. It is primarily localized to the endoplasmic reticulum and Golgi apparatus, where it controls the release of zinc ions from these organelles into the cytosol. This regulation of cytosolic zinc levels is critical for cellular processes such as kinase activation, signal transduction, cell proliferation, glucose metabolism, and maintenance of immune cell function. ZIP7 is implicated in several cancers as a driver of proliferation and resistance to therapy and is required for normal B cell and macrophage activities. Loss or dysregulation of SLC39A7 can cause immunodeficiency, increase ER stress, and disturb cellular homeostasis. ZIP7 overexpression correlates with poor prognosis in several cancers, making it a putative therapeutic target and biomarker[1][2][3][4][6][7].

Other names
ZIP7Solute carrier family 39 member 7ZRT/IRT-like protein 7RING5KE4HKE4D6S2244EH2-KE4AGM9Histidine-rich membrane protein Ke4Really interesting new gene 5 protein
02

Mechanism of action

Not applicable; however, theoretically, SLC39A7 modulators would act by altering zinc efflux from intracellular stores, thereby affecting downstream signaling, especially kinases and cell proliferation pathways[1][3].

03

Biological functions

Zinc transport from endoplasmic reticulum (ER)/Golgi to cytosolRegulation of cytosolic zinc homeostasisSignal transduction (via zinc modulation)Regulation of cell proliferation and growthGlucose metabolism regulationImmune cell (B cell and macrophage) functionProtection against ER stress
04

Disease associations

Cancer (breast, colorectal, cervical, hepatocellular carcinoma)[1][3]Autosomal recessive agammaglobulinemia[3]Immune dysfunction (phagocytosis deficiency, asthma link)[4][6]Potential prognostic marker in oncology[1]
05

Safety considerations

Disruption of SLC39A7 can lead to ER stress, immune dysfunction, and cell proliferation defects[2][3][4]Systemic zinc alteration could have broad, non-specific side effectsTargeting ZIP7 in cancer therapy may impact normal zinc-dependent physiological processes
06

Interacting drugs

No specific drugs directly targeting SLC39A7/ZIP7 are currently listed in major drug databases or literature[7]. (Zinc supplementation can reverse deficiencies caused by SLC39A7 loss-of-function, but SLC39A7 itself is not the drug target[6].)
07

Biomarkers

ZIP7 over-expression (prognostic marker in breast, colorectal, cervical, hepatocellular cancers)[1]Reduced ZIP7 expression in agammaglobulinemia or immune dysfunction[3][4]

Beyond the preview

Go deeper on Zinc transporter SLC39A7 (SLC39A7 (or ZIP7)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc transporter SLC39A7 (SLC39A7 (or ZIP7)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call